SIGA

SIGA Technologies (SIGA)

About SIGA Technologies (SIGA)

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

Details

Daily high

$6.33

Daily low

$6.22

Price at open

$6.28

52 Week High

$9.62

52 Week Low

$4.48

Market cap

452.6M

Dividend yield

0.00%

Volume

274,417

Avg. volume

357,713

P/E ratio

6.07

SIGA Technologies News